Nicotine-induced catecholamine (CA) secretion and inward ionic currents were inhibited by the opioid antagonist naloxone in cultured bovine chromaffin cells. Naloxone inhibited nicotine-induced CA secretion, as detected by an on-line real-time electrochemical technique, in a dose-dependent manner (IC 529 mM). In voltage-clamped chromaffin cells, nicotine (10 mM) evoked an average peak inward 50 current of 2146 pA that was inhibited by low concentrations of naloxone (42% at 0.1 mM). The antagonist also inhibited total charge influx associated with nicotinic receptor activation (53% at 0.1 mM). This provides strong evidence that naloxone modulation of nicotine-induced CA secretion does not involve opioid receptors but results from the direct interaction with the nicotinic receptor itself, which might also be the case for other related opioid compounds.
Introduction
but this effect does not seem to be mediated by opioid receptors since opioid antagonists, like naloxone, have the Chromaffin cells secrete catecholamines (CA) in resame effect [8] . Moreover, it has been shown that activa- 21 sponse to different stimuli [17, 21] . Under physiological tion of opioid k receptors inhibits nicotine-induced Ca conditions, acetylcholine is released from splanchnic nerve entry into chromaffin cells but this effect is not prevented terminals and interacts with nicotinic receptors producing by opioid antagonists like Mr2266 [1] . depolarization of chromaffin cell membrane [18, 23] . This Cholinergic nicotinic receptors are targets for an increas- 21 depolarization opens voltage-dependent Ca channels ing number of drugs and toxins like dihydropyridines [20] , 21 [7, 11] , which produces an increase in intracellular Ca v-agatoxin IVA, a specific blocker of P/ Q type voltage- 21 21 levels ([Ca ] ) [2, 7] and CA and ATP secretion [3, 9] . dependent Ca channels [13] , the diuretic cyclothiazide i Bovine chromaffin cells co-release opioid peptides [22] and tricyclic antidepressants [14] . Interaction of these together with CA following nicotinic receptor stimulation substances with the receptor might interfere with its [19] and their membranes possess m, d and k opioid function. receptors [16] . The secreted opioid peptides might inhibit
To elucidate the mechanism of action of the inhibition nicotine-induced CA secretion from chromaffin cells [15] , of nicotine-induced CA secretion by opioid antagonists, we have studied the effect of naloxone, a well known opioid antagonist, on nicotine-induced CA secretion from induced inward currents. We have found that the antagonist After 10 min, nicotine (10 mM) was applied for 4 s using a is able to inhibit, in a dose-dependent and reversible fast perfusion system under computer control (DAD-12 manner, nicotine-induced CA secretion and inward cursuperfusion system; Adams and List, NY). This nicotine rents.
pulse was repeated three times (S , S , S ) at 15-min 1 2 3 intervals. When used, naloxone was perfused 1 s before and during S . 
Materials and methods

Cell isolation and culture
Reagents
Bovine chromaffin cells were isolated using collagenase Nicotine and naloxone were obtained from Sigma (St digestion and purified through a Percoll gradient as Louis, MO) penicillin and streptomycin from Bio-Whitpreviously described [4] . For electrophysiological recordtaker Bioproducts (Walkersville, MD) and bovine serum 6 ings 10 cells were plated in a 35-mm diameter Petri dish albumin from Calbiochem (La Jolla, CA). All other (Bibby Science Products, Stone, UK). Cultured cells were reagents were obtained from different commercial sources kept at 378C under an atmosphere of 5% CO for up to 5 and were of the maximal available purity. 
Catecholamine secretion 3. Results
Catecholamine secretion experiments were performed as previously described [20] with minor modifications. Briefl-3.1. Catecholamine secretion 6 y, after 2-4 days of culture, chromaffin cells (ca. 2310 cells) were transferred to a perfusion chamber (a 2.3-mm Introduction of nicotine (10 mM) in the perfusion flow diameter, 0.8-mm membrane pore, disposable filter unit) resulted in the detection of a transitory CA secretion and continuously perfused at 2 ml / min with Krebs-Hepes indicating that the agonist induced CA release from the (K-H) solution with the following composition (in mmol / chromaffin cells present in the perfusion chamber [5] . The l): NaCl, 140; KCl, 5; CaCl , 2; MgCl , 1, Hepes, 10; and electrochemical signal was equivalent to the release of 2 2 6 glucose, 5; pH was adjusted to a value between 7.3 and 1.060.3 nmol CA / 10 cells (mean6S.E.M., n53). The 7.4. The cell bed was stimulated with nicotine (10 mM) amplitude of the electrochemical signal tended to decrease every 10 min, beginning after 15 min from the start of as the stimulation of CA secretion with nicotine was perfusion. The effluent solution exiting the perfusion repeated every 10 min (Fig. 1A) . Naloxone produced a chamber was driven into an electrochemical detector marked decrease in the nicotine-induced secretory epi-(Omni 90 potentiostat, Cypress Systems, Lawrence, KS, sodes. The inhibitory effect of naloxone on the nicotine-USA) for direct continuous on-line measurement of catinduced CA release was dose-dependent. The blockade echolamine oxidation current (anodic potential set at 1650 was almost complete at the highest drug concentration mV). When used, naloxone-containing solutions were used, 200 mM (9662% inhibition, n55; Fig. 1, panel A) . perfused 2 min prior to and during nicotine application.
The IC for the blocking effect of naloxone, as de-
50
The inhibitory effect of naloxone was calculated by termined from the dose-response curve, was 29 mM (Fig.  comparing the area under the curve for the electrochemical 1B). signal observed in the presence of the drug with the mean area of the nicotine-induced signals observed before and after it. All the experiments were performed at room 3.2. Nicotine-induced inward currents temperature (22-248C).
Nicotine (10 mM) perfusion for 4 s evoked an inward 2.3. Electrophysiological recording current that amounted to 2146627 pA (n519), producing a total net charge flux of 495656 pC (n519). When the Recording of chromaffin cell nicotinic receptor-activated exposure to nicotine was repeated 15 min later, the ratio currents under voltage-clamp was performed, using the S /S for peak current was 0.9460.07 (n55) and for 2 1 nystatin-perforated patch-clamp technique, as previously charge influx was 1.0260.09 (n55). The presence of described [13] . Chromaffin cells were bathed in a solution naloxone during S produced a marked decrease in both 2 with the following ionic composition (in mmol / l): NaCl peak current and charge influx that was reversible upon 140; KCl 5.9; MgSO 1.2; CaCl 2.5; Hepes 15 and removal of the drug (Fig. 2) . The inhibitory effect of 4 2 glucose 11 (pH 7.4). The intracellular solution had the naloxone was dose-dependent. The blockade reached following composition (in mmol / l): KCl 55; K SO 50;
around 65% for peak current and 68% for total charge 2 4 MgSO 7; Hepes 10 and nystatin 250 mg / ml (pH 7.2). influx at 10 mM drug concentration (Table 1) . likelihood, has removed the locally secreted products. The inhibitory mechanism of opioids on nicotine-evoked CA secretion has been controversial since the lack of stereospecificity [8] and non reversion by opioid antagonists [1, 8] were shown suggesting that specific opioid receptors were not involved in this action. Our electrophysiological data [6, 12, 13, 22] indicating that such a process might be a different experiments.
pharmacologically relevant mechanism to regulate chromaffin cell secretory activity. In summary, the data presented here suggest that the 4. Discussion non-selective opioid antagonist naloxone blocks nicotineinduced CA secretion by a direct interaction with nicotinic The results presented here show that the non-selective receptors, located on the plasmalemma of chromaffin cells, opioid antagonist naloxone potently blocks nicotine-induced CA secretion from chromaffin cells and this effect might be explained by the reversible blockade of nicotine- Table 1 Effect of naloxone on nicotine-induced inward currents and net charge induced inward currents in chromaffin cells. opioids [19] , that might produce a negative feedback on 
